Contraline's implantable contraceptive, Adam, is a non-hormonal gel injected underneath the scrotum, aiming to provide a more convenient alternative to current contraceptive methods like condoms and vasectomies. In trials with 25 men, Adam effectively blocked sperm release for two years. Although there were no serious side effects reported, data on the reversibility of the implant was not included. The product's developer, Kevin Eisenfrats, expressed excitement over this breakthrough, asserting that the results demonstrate the feasibility of a long-term male contraceptive option.
This is really exciting because our goal since day one has been to create a two-year-long male contraceptive - that is what the demand is for.
The implant was inserted via a minimally invasive procedure into the vas deferens, the tube that carries sperm from the testes, under local anaesthetic.
All participants experienced a drop in sperm count, indicating the contraception was effective in preventing sperm from leaving the body.
Collection
[
|
...
]